angiotensin ii has been researched along with paclitaxel in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Camporesi, DA; Sauro, MD; Sudakow, RL | 1 |
Chiou, WJ; Dickinson, R; Opgenorth, TJ; Wu-Wong, JR | 1 |
Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 1 |
Arends, J; Büchert, M; Fasol, U; Fiedler, U; Frost, A; Mross, K; Scharr, D; Scheuenpflug, J | 1 |
Carrera-González, Mdel P; Dueñas, B; Martínez-Ferrol, J; Martínez-Martos, JM; Mayas, MD; Ramírez-Expósito, MJ | 1 |
Dueñas-Rodríguez, B; Martínez-Martos, JM; Ramírez-Exposito, MJ | 1 |
Liang, ZS; Wang, LH; Yang, WX; Yu, SJ; Zhao, ZG | 1 |
2 trial(s) available for angiotensin ii and paclitaxel
Article | Year |
---|---|
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Angiotensin II; Area Under Curve; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Endothelin-1; Female; Humans; Interleukins; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Ultrasonography; Vascular Endothelial Growth Factor A | 2012 |
Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer.
Topics: Aminopeptidases; Angiotensin II; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Endopeptidases; Female; Glutamyl Aminopeptidase; Humans; Middle Aged; Naphthalenes; Neoadjuvant Therapy; Paclitaxel; Reference Values; Renin-Angiotensin System | 2012 |
6 other study(ies) available for angiotensin ii and paclitaxel
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
The anti-tumor agent, taxol, attenuates contractile activity in rat aortic smooth muscle.
Topics: Angiotensin II; Animals; Aorta; Dose-Response Relationship, Drug; Female; Muscle, Smooth, Vascular; Paclitaxel; Phorbol 12,13-Dibutyrate; Rats; Rats, Inbred SHR; Vasoconstriction | 1995 |
Endothelin attenuates apoptosis in human smooth muscle cells.
Topics: Angiotensin II; Annexin A5; Apoptosis; Atrasentan; Cell Survival; DNA Fragmentation; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Muscle, Smooth; Paclitaxel; Pericardium; Phosphatidylserines; Propidium; Prostate; Pyrrolidines | 1997 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Methotrexate; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2005 |
Circulating renin-angiotensin system-regulating specific aminopeptidase activities in pre- and post- menopausal women with breast cancer treated or not with neoadyuvant chemotherapy. A two years follow up study.
Topics: Aminopeptidases; Angiotensin II; Anthracyclines; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; CD13 Antigens; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glutamyl Aminopeptidase; Humans; Immunotherapy; Mastectomy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Postmenopause; Premenopause; Radiotherapy, Adjuvant; Renin-Angiotensin System; Tamoxifen | 2019 |
Control of hypertension in rats using volatile components of leaves of Taxus chinensis var. mairei.
Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Chromatography, Supercritical Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Hydrochlorothiazide; Hypertension; Lipids; Male; Nitric Oxide; Nitroarginine; Phytotherapy; Plant Leaves; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Taxus; Time Factors; Volatilization | 2012 |